BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

541 related articles for article (PubMed ID: 22731672)

  • 1. Preoperative diagnosis of benign thyroid nodules with indeterminate cytology.
    Alexander EK; Kennedy GC; Baloch ZW; Cibas ES; Chudova D; Diggans J; Friedman L; Kloos RT; LiVolsi VA; Mandel SJ; Raab SS; Rosai J; Steward DL; Walsh PS; Wilde JI; Zeiger MA; Lanman RB; Haugen BR
    N Engl J Med; 2012 Aug; 367(8):705-15. PubMed ID: 22731672
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Circulating Myeloid-Derived Suppressor Cells Predict Differentiated Thyroid Cancer Diagnosis and Extent.
    Angell TE; Lechner MG; Smith AM; Martin SE; Groshen SG; Maceri DR; Singer PA; Epstein AL
    Thyroid; 2016 Mar; 26(3):381-9. PubMed ID: 26756227
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Stepwise analysis of thyroid diagnostic modalities with genomic imprinting detection.
    Yang W; Yin M; Zhou J; Zhu Y; Ye B; Shi H; Zhang B; Yue C; Zhang Y; Wu H; Li H; Xia X; Yang S; Ma B
    Chin Clin Oncol; 2024 Apr; 13(2):21. PubMed ID: 38644545
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diagnostic utility of
    Riccio IR; LaForteza AC; Hussein MH; Linhuber JP; Issa PP; Staav J; Fawzy MS; Toraih EA; Kandil E
    EXCLI J; 2024; 23():283-299. PubMed ID: 38487090
    [No Abstract]   [Full Text] [Related]  

  • 5. The role of the ThyGeNEXT oncogene panel used in combination with the expanded miRNA panel ThyraMIRv2 in Indeterminate thyroid nodules: A large, blinded, real-world, observational study.
    Verma T; Marshall C; Dantey KE; Thompson DV; Banizs A; Finkelstein SD; DelTondo J
    Cancer Cytopathol; 2024 May; ():. PubMed ID: 38814813
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Classification of Benign and Malignant Thyroid Nodules Using a Combined Clinical Information and Gene Expression Signatures.
    Zheng B; Liu J; Gu J; Du J; Wang L; Gu S; Cheng J; Yang J; Lu H
    PLoS One; 2016; 11(10):e0164570. PubMed ID: 27776138
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multicenter clinical experience with the Afirma gene expression classifier.
    Alexander EK; Schorr M; Klopper J; Kim C; Sipos J; Nabhan F; Parker C; Steward DL; Mandel SJ; Haugen BR
    J Clin Endocrinol Metab; 2014 Jan; 99(1):119-25. PubMed ID: 24152684
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Highly accurate diagnosis of cancer in thyroid nodules with follicular neoplasm/suspicious for a follicular neoplasm cytology by ThyroSeq v2 next-generation sequencing assay.
    Nikiforov YE; Carty SE; Chiosea SI; Coyne C; Duvvuri U; Ferris RL; Gooding WE; Hodak SP; LeBeau SO; Ohori NP; Seethala RR; Tublin ME; Yip L; Nikiforova MN
    Cancer; 2014 Dec; 120(23):3627-34. PubMed ID: 25209362
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An independent study of a gene expression classifier (Afirma) in the evaluation of cytologically indeterminate thyroid nodules.
    McIver B; Castro MR; Morris JC; Bernet V; Smallridge R; Henry M; Kosok L; Reddi H
    J Clin Endocrinol Metab; 2014 Nov; 99(11):4069-77. PubMed ID: 24780044
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 2015 American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer: The American Thyroid Association Guidelines Task Force on Thyroid Nodules and Differentiated Thyroid Cancer.
    Haugen BR; Alexander EK; Bible KC; Doherty GM; Mandel SJ; Nikiforov YE; Pacini F; Randolph GW; Sawka AM; Schlumberger M; Schuff KG; Sherman SI; Sosa JA; Steward DL; Tuttle RM; Wartofsky L
    Thyroid; 2016 Jan; 26(1):1-133. PubMed ID: 26462967
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of the Multi-Gene ThyroSeq Next-Generation Sequencing Assay on Cancer Diagnosis in Thyroid Nodules with Atypia of Undetermined Significance/Follicular Lesion of Undetermined Significance Cytology.
    Nikiforov YE; Carty SE; Chiosea SI; Coyne C; Duvvuri U; Ferris RL; Gooding WE; LeBeau SO; Ohori NP; Seethala RR; Tublin ME; Yip L; Nikiforova MN
    Thyroid; 2015 Nov; 25(11):1217-23. PubMed ID: 26356635
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular Testing for miRNA, mRNA, and DNA on Fine-Needle Aspiration Improves the Preoperative Diagnosis of Thyroid Nodules With Indeterminate Cytology.
    Labourier E; Shifrin A; Busseniers AE; Lupo MA; Manganelli ML; Andruss B; Wylie D; Beaudenon-Huibregtse S
    J Clin Endocrinol Metab; 2015 Jul; 100(7):2743-50. PubMed ID: 25965083
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The impact of benign gene expression classifier test results on the endocrinologist-patient decision to operate on patients with thyroid nodules with indeterminate fine-needle aspiration cytopathology.
    Duick DS; Klopper JP; Diggans JC; Friedman L; Kennedy GC; Lanman RB; McIver B
    Thyroid; 2012 Oct; 22(10):996-1001. PubMed ID: 22873825
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A prospective assessment defining the limitations of thyroid nodule pathologic evaluation.
    Cibas ES; Baloch ZW; Fellegara G; LiVolsi VA; Raab SS; Rosai J; Diggans J; Friedman L; Kennedy GC; Kloos RT; Lanman RB; Mandel SJ; Sindy N; Steward DL; Zeiger MA; Haugen BR; Alexander EK
    Ann Intern Med; 2013 Sep; 159(5):325-32. PubMed ID: 24026318
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Implications of a suspicious afirma test result in thyroid fine-needle aspiration cytology: an institutional experience.
    Lastra RR; Pramick MR; Crammer CJ; LiVolsi VA; Baloch ZW
    Cancer Cytopathol; 2014 Oct; 122(10):737-44. PubMed ID: 25123499
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Targeted next-generation sequencing panel (ThyroSeq) for detection of mutations in thyroid cancer.
    Nikiforova MN; Wald AI; Roy S; Durso MB; Nikiforov YE
    J Clin Endocrinol Metab; 2013 Nov; 98(11):E1852-60. PubMed ID: 23979959
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Integrated genomic characterization of papillary thyroid carcinoma.
    Cancer Genome Atlas Research Network
    Cell; 2014 Oct; 159(3):676-90. PubMed ID: 25417114
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular diagnostic testing and the indeterminate thyroid nodule.
    Yip L
    Curr Opin Oncol; 2014 Jan; 26(1):8-13. PubMed ID: 24225416
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Analytical performance of the ThyroSeq v3 genomic classifier for cancer diagnosis in thyroid nodules.
    Nikiforova MN; Mercurio S; Wald AI; Barbi de Moura M; Callenberg K; Santana-Santos L; Gooding WE; Yip L; Ferris RL; Nikiforov YE
    Cancer; 2018 Apr; 124(8):1682-1690. PubMed ID: 29345728
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 28.